Cardiovascular Bio Therapeutics

CardioVascular BioTherapeutics, Inc. (CVBT) is a development-stage biopharmaceutical company focused on advancing biologic candidates for the treatment of diabetes, severe ischemic heart disease, peripheral artery disease, erectile dysfunction, and occlusive stroke. CVBT concentrates on research and development with the aim of improving the quality of life for patients with ischemic tissues and organs.